The U.S. Patent Act provides that an inventor is barred from obtaining patent rights for an invention, and the invention goes into the public domain, when a patent application is not filed within one year of certain activities of the inventor that make the invention available to the public.
We sheepishly take notice that we have spent precious little blog space in the last number of months on the issue of retaliation, which is a big part of discrimination law and a major cause in the rise of discrimination charges.
Victims. The word conveys a sense of passiveness-something happened to a person. And for a while, that was an apt description for the lawyers who became casualties of the Great Reset back in 2008.
It has become an annual New Year’s tradition in California — employers getting up to speed on a host of new employment laws that will affect them in the coming year.
In the past three years, there has been considerable activity on the Title IX/Sexual Assault legal front. We have all read about the increase in claims brought by victims against their institutions through the complaint procedures of the U.S. Department of Education’s Office for Civil Rights.
I have written several times that I believe one-shot client development training programs don’t work. Those programs are analogous to going on a crash diet. Before long, like the crash dieter, those who participate are back where they started.
A federal district court in Michigan recently granted summary judgment for the plaintiff, (you read that correctly), ruling that the employer was liable for disability discrimination as a matter of law.
At this point, I’m well aware that I tend to sound like an old crank when reviewing class action scholarship; much of it repeats the same old stuff, predicts the imminent demise of the class action in its current form, and looks at the same Supreme Court cases instead of digging into where the real action happens.
This past year was a big one for the Food Safety Modernization Act (FSMA), with the U.S. Food and Drug Administration (FDA) proposing six of its seven major rules. Now, there are a number of deadlines facing the agency in 2014.